Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

Purpose The specific indications of somatostatin analogs (SSAs) in patients with
neuroendocrine tumor (NET) emerged over the time. The objective of this review is to …

Growth hormone (GH) is a crucial regulator of growth, cell reproduction, and regeneration;
and it is controlled by growth hormone-releasing hormone (GHRH) and somatostatin …

Background: Neuroendocrine neoplasms (NENs) are slow-growing tumors. Sarcopenia is
defined as the loss of muscle mass, strength, and physical performance. First-line NEN …

Unsymmetric disulfides are prevalent in natural products and are essential in medicinal
chemistry and materials science, but their robust synthesis poses significant challenges. In …

Precision medicine is growing as an innovative approach in the neuroendocrine field,
aiming to obtain a detailed understanding of the disease, including epigenetic and omics …

The incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP NEN) is
increasing at a rapid pace and is becoming an increasingly important consideration in …

A key challenge in cancer treatment is the effective delivery of drugs into deep regions of
tumor tissues, which are impermeable due to abnormal vascular network, increased …

Introduction The somatostatin analogs (SSA) octreotide and lanreotide are a mainstay in the
treatment of neuroendocrine tumors (NET). The two pivotal trials differed considerably in …

Conjugation of radiofluorinated prosthetic groups to primary amines of peptides in an
aqueous medium is still considerably challenging. Herein, we report a one-pot cascade …